US Corporate Board Director Changes SEC Filings — December 16, 2025

17-12-2025

Ingersoll Rand Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure/Election of Officers), Regulation FD disclosure under Item 7.01, and exhibits under Item 9.01. No specific details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the filing summary. Analysis limited to disclosed metadata; critical details NOT_DISCLOSED.

• ·Item 5.02 indicates officer change (appointment, departure, or compensatory arrangement), but key position (e.g., CEO/CFO) and nature NOT_DISCLOSED.
• ·Item 7.01 suggests Regulation FD disclosure, potentially material non-public information shared.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED.

17-12-2025

Winnebago Industries Inc filed an 8-K on 2025-12-17 disclosing matters under Item 5.02 (officer/director changes and compensatory arrangements), Item 5.07 (shareholder votes), and Item 9.01 (exhibits). No specific details on positions affected, reasons for changes, vote outcomes, or quantitative data are provided in the filing summary. Analysis limited to disclosed items; all leadership change facts are NOT_DISCLOSED.

• ·Item 5.02 flags potential officer/departure or appointment, but key details (position, internal/external, reason, timing) NOT_DISCLOSED
• ·Item 5.07 indicates shareholder meeting results, but specifics NOT_DISCLOSED
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted: all NOT_DISCLOSED

17-12-2025

Zura Bio Ltd filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the officer's position, name, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited due to lack of explicit filing content.

• ·Item 5.02 officer change disclosure filed 2025-12-17
• ·AccNo: 0001104659-25-121826, Size: 193 KB
• ·Sector not specified; no quantitative data (e.g., shares, values: NOT_DISCLOSED)

17-12-2025

PG&E Corp filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details on the officer position, appointment/resignation, reasons, or quantitative data are NOT_DISCLOSED in the provided summary. Analysis is limited to filing items with no factual content on leadership impacts.

• ·Item 5.02: Departure of directors/officers or election/appointment (details NOT_DISCLOSED)
• ·Item 5.03: Amendments to governing documents or fiscal year change (details NOT_DISCLOSED)
• ·Item 8.01: Other events (details NOT_DISCLOSED)
• ·Quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED
• ·Critical missing info: Officer name, position (e.g., CEO/CFO), reason for change, board impacts

17-12-2025

Movano Inc. filed an 8-K on December 17, 2025, disclosing officer changes or elections (Item 5.02), shareholder vote results (Item 5.07), and exhibits (Item 9.01). No specific details on positions affected, reasons, outcomes, or quantitative data are provided in the summary. Analysis is limited to the high-level items triggered, with all key facts NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or compensatory arrangements for officers/directors, but specifics NOT_DISCLOSED.
• ·Item 5.07 reports submission of matters to security holder vote, outcomes NOT_DISCLOSED.
• ·No quantitative data (transaction values, shares, percentages, financial metrics) extracted; all NOT_DISCLOSED.

17-12-2025

SharpLink Gaming, Inc. filed an 8-K on December 17, 2025, reporting an officer change (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), Regulation FD disclosure (Item 7.01), other events (Item 8.01), and exhibits (Item 9.01). No specific details on the officer position, appointment/resignation, reasons, or quantitative data are disclosed in the provided summary. Analysis limited to filing items; critical facts like leadership details are NOT_DISCLOSED.

• ·Item 5.02 discloses departure, election, or appointment of officers/directors
• ·Item 5.03 indicates governance document amendments
• ·Additional items (7.01, 8.01, 9.01) suggest broader material disclosures

17-12-2025

Five9, Inc. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements) and exhibits under Item 9.01. No specific details on the officer, position, reason, or nature of change are provided in the filing summary. Analysis is limited; all quantitative data and key facts are NOT_DISCLOSED.

• ·Item 5.02 filing signals potential leadership transition, but specifics (position, appointment/resignation, reason) NOT_DISCLOSED.
• ·Timely SEC disclosure (within 4 business days requirement met).
• ·No financial metrics, share counts, transaction values, or board impacts mentioned.

17-12-2025

Progyny, Inc. filed an 8-K on 2025-12-17 disclosing Item 5.02, indicating departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specifics on positions, individuals, appointment/resignation status, reasons, or quantitative data (e.g., transaction values, share counts) are provided—ALL NOT_DISCLOSED. Analysis limited to filing metadata; neutral signal pending full details.

• ·Item 5.02 event: Officer/director change or compensatory arrangements
• ·Filed 2025-12-17 (AccNo: 0001551306-25-000218); timely SEC compliance
• ·Quantitative data (transaction value, shares, % changes, financial metrics): ALL NOT_DISCLOSED

17-12-2025

SEI Investments Co filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), along with other events (Item 8.01) and exhibits (Item 9.01). Specific details on the officer position, appointment/resignation status, reasons, or quantitative data are NOT_DISCLOSED in the provided summary. This appears to be a standard governance disclosure with no explicit facts on impact.

• ·Officer change reported under Item 5.02
• ·Additional disclosures in Items 8.01 (Other Events) and 9.01 (Exhibits)
• ·Filed timely on 2025-12-17; no names, positions, or reasons specified

17-12-2025

Essential Properties Realty Trust, Inc. filed an 8-K on December 17, 2025, reporting an officer change under Item 5.02 (Departure/Election/Appointment of Officers/Directors or Compensatory Arrangements), with Regulation FD disclosure (Item 7.01) and exhibits (Item 9.01). No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis limited to metadata; critical facts like names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 covers officer/director departures, elections, appointments, or compensatory arrangements - routine SEC disclosure.
• ·Filed on 2025-12-17 via AccNo 0001728951-25-000188, compliant with 4-business-day 8-K requirement.
• ·No quantitative data (e.g., transaction values, share counts, percentages) or board outcomes mentioned; all NOT_DISCLOSED.

17-12-2025

CPS Technologies Corp filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on position affected, appointment/resignation status, reasons, or quantitative data are provided. Analysis limited to filing summary; critical facts NOT_DISCLOSED.

• ·Item 5.02 disclosure for officer change, filed within SEC 4-business-day requirement.
• ·No details on key position (e.g., CEO/CFO), internal/external hire, or reasons stated.
• ·Quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED.

17-12-2025

CNS Pharmaceuticals, Inc. filed a Form 8-K on December 17, 2025, disclosing an event under Item 5.02 related to departure of directors/officers, elections, appointments, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were filed. No specific details on positions, individuals, reasons, or quantitative data are disclosed.

• ·Item 5.02: Officer/director change or compensatory arrangement
• ·Filed 2025-12-17; AccNo: 0001683168-25-009208
• ·Item 9.01: Exhibits included; no financial metrics or transaction details provided
• ·All quantitative data (transaction value, share count, percentages): NOT_DISCLOSED

17-12-2025

Quantum Computing Inc. filed an 8-K on 2025-12-17 disclosing an officer or director change under Item 5.02, with exhibits under Item 9.01. No specifics on position, individual, reason, or quantitative details provided in the filing summary. Event type indicates potential leadership transition but lacks material facts for deeper analysis.

• ·Item 5.02: Departure, election, or appointment of directors/officers or compensatory arrangements
• ·Item 9.01: Financial statements and exhibits filed (320 KB)
• ·No names, positions, reasons, or quantitative data (e.g., shares, values) disclosed

17-12-2025

King Resources, Inc. disclosed an officer change via 8-K filing on December 17, 2025, under Item 5.02 (Departure of Directors/Officers; Election/Appointment; Compensatory Arrangements) and Item 9.01 (Exhibits). No specific details on position, individual, appointment/resignation, or reasons are stated. All quantitative data and key facts NOT_DISCLOSED.

• ·Item 5.02 triggered for unspecified officer/director change or compensation.
• ·Filed timely per SEC 8-K rules (within 4 business days).
• ·Exhibits attached (Item 9.01), but contents NOT_DISCLOSED.

17-12-2025

Treasure Global Inc filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer change or compensatory arrangements
• ·Filed 2025-12-17; AccNo: 0001213900-25-122618
• ·Sector not specified; no quantitative data extracted (all NOT_DISCLOSED)

17-12-2025

CF Bankshares Inc. filed an Item 5.02 8-K on December 17, 2025, disclosing an officer change involving departure, election, appointment, or compensatory arrangements, but specific details on position, individual, reason, or terms are NOT_DISCLOSED. No quantitative data or further context provided in the summary. Analysis limited to standard SEC disclosure requirements.

• ·Item 5.02 disclosure for officer/director changes or compensatory arrangements
• ·No details on key position (CEO/CFO/etc.), appointment/resignation, or reasons stated
• ·Filed within SEC 4-business-day window; no board outcomes or financial metrics mentioned

17-12-2025

Xcel Energy Inc filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). No specific details on the officer's position, nature of change (appointment/resignation), reasons, or quantitative data are disclosed in the provided summary. Analysis limited to filing metadata.

• ·Item 5.02 filing indicates officer-related event (departure, election, appointment, or compensatory arrangement).
• ·Filed within SEC 8-K requirements (within 4 business days); AccNo: 0000072903-25-000273.
• ·No names, positions, reasons, or financial metrics explicitly stated - all marked NOT_DISCLOSED.

17-12-2025

The filing is an 8-K Item 5.02 disclosing an unspecified officer change on December 17, 2025 (AccNo: 0001371451-25-000023). No details on the officer's position, appointment/resignation status, reasons, or quantitative data are provided in the excerpt. Analysis is limited to filing metadata, indicating routine SEC disclosure without directional implications.

• ·Item 5.02: Officer change event filed on 2025-12-17, compliant with 4-business-day SEC requirement.
• ·No specifics on key position (e.g., CEO/CFO), type (appointment/resignation), or reasons disclosed.
• ·All quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED.

17-12-2025

BioMarin Pharmaceutical Inc. disclosed an Item 5.02 event on December 17, 2025, regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on individuals, positions, reasons, or quantitative data are provided in the filing summary. This is a standard SEC 8-K disclosure with limited information available for analysis.

• ·Item 5.02 filing on officer/director changes or compensatory arrangements
• ·Filed December 17, 2025; AccNo: 0001193125-25-322704
• ·No names, positions, reasons, or numerical data explicitly stated

17-12-2025

Fulton Financial Corp filed an 8-K on December 17, 2025, disclosing Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. No specific details on positions affected, individuals, reasons, or quantitative data are provided in the available summary. This appears to be a routine disclosure with limited visibility into implications.

• ·Item 5.02 filing: Covers officer/director changes or compensatory arrangements
• ·No details on key positions (e.g., CEO, CFO), appointment/resignation type, or reasons disclosed
• ·No quantitative data (transaction values, share counts, percentages, financial metrics) mentioned: all NOT_DISCLOSED

17-12-2025

MACH NATURAL RESOURCES LP filed an 8-K on December 17, 2025, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements. No specific names, positions, reasons, or details are provided in the available information. Analysis is constrained by lack of explicit filing content.

• ·Item 5.02 event: Officer or director change or compensatory arrangement
• ·Filed December 17, 2025; AccNo: 0001213900-25-122784
• ·No quantitative data, names, or reasons disclosed

17-12-2025

Insulet Corp filed a Form 8-K on December 17, 2025, disclosing an event under Item 5.02 related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.

• ·Item 5.02: Covers officer/director departures, elections, appointments, or compensatory arrangements - specifics NOT_DISCLOSED
• ·Item 9.01: Financial statements and exhibits filed
• ·Event filed within SEC 8-K timeline (Dec 17, 2025); no quantitative data (e.g., share counts, values) mentioned

17-12-2025

Delta Air Lines, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, nature of change, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer departure, appointment, election, or compensatory arrangement
• ·Filed within SEC 8-K timeline (within 4 business days)
• ·No names, positions, reasons, or numerical data disclosed

17-12-2025

Zevra Therapeutics, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, appointment/resignation status, reasons, or quantitative data are disclosed in the provided filing summary. Analysis is limited to factual disclosure of the event type without substantive content.

• ·Item 5.02 indicates an officer change event (departure, election, appointment, or compensatory arrangements)
• ·Item 9.01 lists financial statements and exhibits (details NOT_DISCLOSED)
• ·No names, positions, reasons, timing, or quantitative metrics (e.g., transaction value, share count) mentioned

17-12-2025

UNITED NATURAL FOODS INC filed an 8-K on 2025-12-17 disclosing an officer or director change (Item 5.02), submission of matters to shareholder vote (Item 5.07), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No specific details on positions, reasons, or individuals affected are provided. Quantitative data such as transaction values, share counts, or financial metrics are NOT_DISCLOSED.

• ·Item 5.02 indicates departure, election, or appointment of directors/officers, but key position, type (appointment/resignation), reason, and timing NOT_DISCLOSED
• ·Item 5.07 reports shareholder vote outcomes, details NOT_DISCLOSED
• ·Items 8.01 and 9.01 cover other events and exhibits, specifics NOT_DISCLOSED

17-12-2025

Cassava Sciences Inc. disclosed an officer change via 8-K filing on December 17, 2025, under Item 5.02 (departures, elections, appointments, or compensatory arrangements of officers/directors) and Item 9.01 (financial statements/exhibits). No specifics on position, individual, appointment/resignation status, reasons, or quantitative data are stated. Analysis limited to filing metadata; all details NOT_DISCLOSED.

• ·Item 5.02 triggered: Officer/director change or compensatory arrangement
• ·No key position (CEO/CFO/etc.), reason, timing, or internal/external status disclosed
• ·Quantitative data (transaction value, shares, percentages, financial metrics): NOT_DISCLOSED

17-12-2025

Splash Beverage Group, Inc. filed an 8-K on 2025-12-17 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on position, individual, reason, or quantitative data are provided in the filing summary.

• ·Item 5.02 indicates officer change event, but key details (position, appointment/resignation, reason) NOT_DISCLOSED
• ·Timely SEC filing (within 4 business days requirement)
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED

17-12-2025

Addentax Group Corp. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or quantitative data are provided in the summary.

• ·Item 5.02 indicates officer change or compensatory arrangement, but key position (e.g., CEO/CFO) NOT_DISCLOSED
• ·Filed within SEC 8-K timeline (4 business days), compliant with disclosure requirements
• ·No board composition, succession details, or financial metrics disclosed

17-12-2025

Tompkins Financial Corp filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). No specific details on the officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or quantitative data are provided. This is a routine SEC disclosure with limited information available.

• ·Item 5.02 filing for officer change or compensatory arrangements
• ·Filed 2025-12-17 (AccNo: 0001999371-25-020552)
• ·No names, positions, reasons, or financial metrics disclosed

17-12-2025

N-able, Inc. filed a Form 8-K on December 17, 2025, under Item 5.02 disclosing an officer change, director election, appointment, or compensatory arrangement. No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are provided in the summary. Analysis is limited; all key facts such as leadership role, timing, and impacts are NOT_DISCLOSED.

• ·Item 5.02 filing signals potential officer departure, appointment, or compensation update.
• ·No details on key position (e.g., CEO/CFO), internal/external hire, reasons, or board impacts disclosed.
• ·Quantitative data (transaction values, shares, percentages, financial metrics) all NOT_DISCLOSED.

17-12-2025

U.S. GoldMining Inc. filed an 8-K on December 17, 2025 (AccNo: 0001493152-25-028151), disclosing Item 5.02 related to departure of directors/officers, election/appointment of directors/officers, or compensatory arrangements. No specific details on positions, individuals, reasons, or quantitative data are provided in the filing summary. Analysis is limited due to lack of explicit content.

• ·Item 5.02 filing indicates officer or director change event
• ·Filed within SEC 4-business-day requirement
• ·No quantitative data (e.g., shares, values, percentages) disclosed: NOT_DISCLOSED

17-12-2025

Ardeylix, Inc. filed an 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment), with additional Items 8.01 (Other Events) and 9.01 (Exhibits). No specific details on the officer, position (e.g., CEO/CFO), reason, or quantitative data are provided in the summary. Analysis is limited; all key facts such as names, roles, and impacts are NOT_DISCLOSED.

• ·Item 5.02 filing signals officer departure, election, or appointment, but position, internal/external status, and reason NOT_DISCLOSED.
• ·No quantitative data extracted: Transaction Value NOT_DISCLOSED, Share Count NOT_DISCLOSED, Percentage Changes NOT_DISCLOSED, Financial Metrics NOT_DISCLOSED.
• ·Compliance with SEC 8-K timing met (filed same day); governance/stock impact indeterminable without details.

17-12-2025

Bausch & Lomb Corp filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election/Appointment). No specific details on the position affected, nature of change (appointment/resignation), reasons, or quantitative data are provided in the filing summary. Item 9.01 references financial statements/exhibits, but contents are NOT_DISCLOSED.

• ·Event involves officer change per Item 5.02, filed timely on 2025-12-17.
• ·No names, positions (e.g., CEO/CFO), reasons, or succession details disclosed.
• ·Quantitative data (transaction values, shares, percentages) all NOT_DISCLOSED.

17-12-2025

Cisco Systems, Inc. filed an 8-K on December 17, 2025, disclosing matters under Item 5.02 (officer/director changes or compensatory arrangements), Item 5.07 (shareholder vote results), and Item 9.01 (exhibits). No specific details on officers, positions, reasons, votes, or quantitative data provided in the summary. Event appears informational with no disclosed material impacts.

• ·Item 5.02 triggered: Indicates officer departure, election, appointment, or compensatory arrangements (details NOT_DISCLOSED).
• ·Item 5.07 triggered: Shareholder matters submitted to vote (outcomes NOT_DISCLOSED).
• ·No quantitative data (e.g., transaction values, shares, percentages) extracted: ALL NOT_DISCLOSED.
• ·Critical missing info: Officer names, positions (e.g., CEO/CFO), appointment/resignation type, reasons, vote results.

17-12-2025

Shore Bancshares Inc disclosed an officer change via Form 8-K filed on December 17, 2025, under Item 5.02 (Departure/Election/Appointment of Officers/Directors; Compensatory Arrangements) and Item 9.01 (Exhibits). No specific details on position, individual, reason, or quantitative data are provided in the summary.

• ·Item 5.02 covers officer/director changes or compensatory arrangements
• ·Item 9.01 lists financial statements and exhibits
• ·All specifics (names, roles, reasons, numbers) NOT_DISCLOSED

17-12-2025

Crinetics Pharmaceuticals, Inc. filed a Form 8-K on December 17, 2025, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on the officer, position, reason, or nature of change (e.g., resignation, appointment) are provided in the summary.

• ·Item 5.02 filing indicates officer-related event (departure, election, appointment, or compensatory arrangements)
• ·Filed timely on 2025-12-17 per SEC 8-K requirements (within 4 business days)
• ·No quantitative data (e.g., share counts, transaction values) or specifics (names, positions, reasons) disclosed

17-12-2025

Coursera, Inc. filed an 8-K on December 17, 2025, under Item 5.02 disclosing an officer change involving departure, election, appointment, or compensatory arrangements. No specific details on the officer's position, name, reason for change, or quantitative data are provided in the summary. This is a standard SEC disclosure with limited information available for analysis.

• ·Item 5.02 filing on officer change (departure, election, appointment, or compensatory arrangements)
• ·Filed on 2025-12-17, AccNo: 0001140361-25-045859
• ·All quantitative data (transaction value, share count, percentages, financial metrics): NOT_DISCLOSED

17-12-2025

USBC, Inc. filed an 8-K on 2025-12-17 disclosing officer/director changes (Item 5.02), bylaws amendments or fiscal year change (Item 5.03), and exhibits (Item 9.01). No specific details on positions affected, appointment/resignation status, reasons, or quantitative data are provided. Analysis limited to filing items triggered; critical facts NOT_DISCLOSED.

• ·Item 5.02: Departure/election/appointment of directors/officers or compensatory arrangements
• ·Item 5.03: Amendments to articles/bylaws or fiscal year change
• ·Item 9.01: Financial statements/exhibits filed; no numerical values or specifics extracted (ALL NOT_DISCLOSED)